David Zhao

VHVI reaches milestone in heart valve procedures

Vanderbilt Heart and Vascular Institute recently performed its 100th transcatheter aortic heart valve-replacement (TAVR) on 91-year-old Murline Westover from Lavinia, Tenn.

Heart illustration

Vanderbilt Heart to participate in CoreValve clinical trial

Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart’s aortic valve.